Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990 May;44(5):777-80.

[Inhalation bronchodilators in infancy--comparative study between salbutamol and ipratropium bromide]

[Article in German]
Affiliations
  • PMID: 2141691
Clinical Trial

[Inhalation bronchodilators in infancy--comparative study between salbutamol and ipratropium bromide]

[Article in German]
J Riedler. Pneumologie. 1990 May.

Abstract

The effectiveness of bronchodilators in infancy still remains uncertain. The objective of the present study was, on the basis of clinical scores, to determine the effect of salbutamol and ipratropium bromide in the treatment of acute airways obstruction in infants. For this purpose, we investigated a total of 22 infants whose ages ranged between 1 and 12 months and who were randomized to three different treatment groups. Infants in group 1 were given 0.9% NaCl to inhale, those in group 2 received ipratropium bromide, and those in group 3 salbutamol. The response to treatment was assessed on the basis of a decrease in the clinical score. A statistically significant decrease in the score was found only for those infants given ipratropium to inhale. None of the infants in this group failed to respond to treatment. Ipratropium bromide proved to be more effective than salbutamol in the treatment of infants with acute airways obstruction.

PubMed Disclaimer

LinkOut - more resources